Thinly traded nano cap Co-Diagnostics (NASDAQ:CODX) jumps 181% premarket on increased volume in reaction to its announcement that
it has completed the principle design work for a PCR screening test for
the coronavirus, 2019-nCoV, driving the current outbreak in China.
There has been only one confirmed case in the U.S. so far, a man in the Seattle area.
https://seekingalpha.com/news/3533828-co-diagnostics-readies-coronavirus-test-shares-rocket-181-premarket
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.